SEC Form 3 · accession 0001235802-18-000140
ReShape Lifesciences Inc. · RSLS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arda Minocherhomjee Ph.D.
Director
Period of report
Aug 13, 2018
Accepted (ET)
Aug 29, 2018 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001371217
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par value per share | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.